PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.64%
Some net income increase while MCHP is negative at -12.08%. John Neff would see a short-term edge over the struggling competitor.
4.72%
Some D&A expansion while MCHP is negative at -2.44%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
163.22%
Some yoy growth while MCHP is negative at -66.51%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
840.00%
Well above MCHP's 1236.92% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
2.33%
Some inventory rise while MCHP is negative at -1288.64%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
375.64%
Lower 'other working capital' growth vs. MCHP's 1251.91%. David Dodd would see fewer unexpected short-term demands on cash.
179.59%
Well above MCHP's 128.56%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
83.07%
Operating cash flow growth above 1.5x MCHP's 37.26%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-75.10%
Both yoy lines negative, with MCHP at -3.68%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-726.77%
Both yoy lines negative, with MCHP at -85.01%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-0.50%
We reduce yoy sales while MCHP is 161.03%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
100.00%
We have some outflow growth while MCHP is negative at -83.29%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-304.19%
Both yoy lines negative, with MCHP at -20.67%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
37.93%
Stock issuance far above MCHP's 29.32%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
61.61%
Buyback growth at 50-75% of MCHP's 95.39%. Martin Whitman questions partial disadvantage in per-share enhancements if competitor repurchases more.